Jazz Pharmaceuticals plc Ireland

Jazz Pharmaceuticals to Report 2023 Full Year and Fourth Quarter Financial Results on February 28, 2024

for more information.

Investors: 
Andrea N. Flynn, Ph.D.
Vice President, Head, Investor Relations
Jazz Pharmaceuticals plc
[e-mail]
Ireland [phone]
U.S. [phone]

Media Contact:
Kristin Bhavnani
Head of Global Corporate Communications
Jazz Pharmaceuticals plc
[e-mail]
Ireland [phone]
U.S. [phone]

Logo - https://mma.prnewswire.com/media/272253/Jazz_Pharmaceuticals_New_Logo.jpg

View original content:https://www.prnewswire.co.uk/news-releases/jazz-pharmaceuticals-to-report-2023-full-year-and-fourth-quarter-financial-results-on-february-28-2024-302062153.html